aluates Reports

$ 0.0

Automative

Global Pertuzumab Market Research Report 2025

Published Date: January 2025

Report Code: QYRE-Auto-29I8381

Global Pertuzumab Market Insights and Forecast to 2028

BUY CHAPTERS

Global Pertuzumab Market Research Report 2025

Code: QYRE-Auto-29I8381

Report

January 2025

Pages:80

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novartis

Pfizer Inc

Abnova Corporation

InvivoGen

Celltrion

Biocon Ltd.

Bio-Techne

Pertuzumab Market Size

The global market for Pertuzumab was valued at US$ 264 million in the year 2024 and is projected to reach a revised size of US$ 392 million by 2031, growing at a CAGR of 5.9% during the forecast period.

Pertuzumab Market

Patuzumab is a monoclonal antibody. It was the first monoclonal antibody called an "HER dimerization inhibitor." By binding to HER2, it blocks heterodimerization of HER2 with other HER receptors, slowing tumor growth.

Pertuzumab, in combination with trastuzumab, is used in HER2-positive breast cancer treatment. Market trends include its continued use in combination therapies and ongoing clinical trials to explore its potential in other cancer types.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pertuzumab, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pertuzumab.

The Pertuzumab market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pertuzumab market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pertuzumab manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pertuzumab Market Report

Report Metric	Details
Report Name	Pertuzumab Market
Accounted market size in year	US$ 264 million
Forecasted market size in 2031	US$ 392 million
CAGR	5.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Human Source Animal Source
Segment by Application	Hospital Medical Center
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Novartis AG, Pfizer, Abnova Corporation, InvivoGen, Celltrion, Biocon Limited, Bio-Techne
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pertuzumab manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pertuzumab in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Pertuzumab Market growing?

Ans: The Pertuzumab Market witnessing a CAGR of 5.9% during the forecast period 2025-2031.

What is the Pertuzumab Market size in 2031?

Ans: The Pertuzumab Market size in 2031 will be US$ 392 million.

Who are the main players in the Pertuzumab Market report?

Ans: The main players in the Pertuzumab Market are Novartis AG, Pfizer, Abnova Corporation, InvivoGen, Celltrion, Biocon Limited, Bio-Techne

What are the Application segmentation covered in the Pertuzumab Market report?

Ans: The Applications covered in the Pertuzumab Market report are Hospital, Medical Center

What are the Type segmentation covered in the Pertuzumab Market report?

Ans: The Types covered in the Pertuzumab Market report are Human Source, Animal Source

Recommended Reports

Monoclonal Antibody Drugs

Cancer Treatment Drugs

Breast Cancer Drugs

1 Pertuzumab Market Overview

1.1 Product Definition

1.2 Pertuzumab by Type

1.2.1 Global Pertuzumab Market Value Comparison by Type (2024 VS 2031)

1.2.2 Human Source

1.2.3 Animal Source

1.3 Pertuzumab by Application

1.3.1 Global Pertuzumab Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Medical Center

1.4 Global Pertuzumab Market Size Estimates and Forecasts

1.4.1 Global Pertuzumab Revenue 2020-2031

1.4.2 Global Pertuzumab Sales 2020-2031

1.4.3 Global Pertuzumab Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Pertuzumab Market Competition by Manufacturers

2.1 Global Pertuzumab Sales Market Share by Manufacturers (2020-2025)

2.2 Global Pertuzumab Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Pertuzumab Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Pertuzumab, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Pertuzumab, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Pertuzumab, Product Type & Application

2.7 Global Key Manufacturers of Pertuzumab, Date of Enter into This Industry

2.8 Global Pertuzumab Market Competitive Situation and Trends

2.8.1 Global Pertuzumab Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Pertuzumab Players Market Share by Revenue

2.8.3 Global Pertuzumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Pertuzumab Market Scenario by Region

3.1 Global Pertuzumab Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Pertuzumab Sales by Region: 2020-2031

3.2.1 Global Pertuzumab Sales by Region: 2020-2025

3.2.2 Global Pertuzumab Sales by Region: 2026-2031

3.3 Global Pertuzumab Revenue by Region: 2020-2031

3.3.1 Global Pertuzumab Revenue by Region: 2020-2025

3.3.2 Global Pertuzumab Revenue by Region: 2026-2031

3.4 North America Pertuzumab Market Facts & Figures by Country

3.4.1 North America Pertuzumab Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Pertuzumab Sales by Country (2020-2031)

3.4.3 North America Pertuzumab Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Pertuzumab Market Facts & Figures by Country

3.5.1 Europe Pertuzumab Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Pertuzumab Sales by Country (2020-2031)

3.5.3 Europe Pertuzumab Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Pertuzumab Market Facts & Figures by Region

3.6.1 Asia Pacific Pertuzumab Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Pertuzumab Sales by Region (2020-2031)

3.6.3 Asia Pacific Pertuzumab Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Pertuzumab Market Facts & Figures by Country

3.7.1 Latin America Pertuzumab Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Pertuzumab Sales by Country (2020-2031)

3.7.3 Latin America Pertuzumab Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Pertuzumab Market Facts & Figures by Country

3.8.1 Middle East and Africa Pertuzumab Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Pertuzumab Sales by Country (2020-2031)

3.8.3 Middle East and Africa Pertuzumab Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Pertuzumab Sales by Type (2020-2031)

4.1.1 Global Pertuzumab Sales by Type (2020-2025)

4.1.2 Global Pertuzumab Sales by Type (2026-2031)

4.1.3 Global Pertuzumab Sales Market Share by Type (2020-2031)

4.2 Global Pertuzumab Revenue by Type (2020-2031)

4.2.1 Global Pertuzumab Revenue by Type (2020-2025)

4.2.2 Global Pertuzumab Revenue by Type (2026-2031)

4.2.3 Global Pertuzumab Revenue Market Share by Type (2020-2031)

4.3 Global Pertuzumab Price by Type (2020-2031)

5 Segment by Application

5.1 Global Pertuzumab Sales by Application (2020-2031)

5.1.1 Global Pertuzumab Sales by Application (2020-2025)

5.1.2 Global Pertuzumab Sales by Application (2026-2031)

5.1.3 Global Pertuzumab Sales Market Share by Application (2020-2031)

5.2 Global Pertuzumab Revenue by Application (2020-2031)

5.2.1 Global Pertuzumab Revenue by Application (2020-2025)

5.2.2 Global Pertuzumab Revenue by Application (2026-2031)

5.2.3 Global Pertuzumab Revenue Market Share by Application (2020-2031)

5.3 Global Pertuzumab Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Novartis AG

6.1.1 Novartis AG Company Information

6.1.2 Novartis AG Description and Business Overview

6.1.3 Novartis AG Pertuzumab Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Novartis AG Pertuzumab Product Portfolio

6.1.5 Novartis AG Recent Developments/Updates

6.2 Pfizer

6.2.1 Pfizer Company Information

6.2.2 Pfizer Description and Business Overview

6.2.3 Pfizer Pertuzumab Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Pfizer Pertuzumab Product Portfolio

6.2.5 Pfizer Recent Developments/Updates

6.3 Abnova Corporation

6.3.1 Abnova Corporation Company Information

6.3.2 Abnova Corporation Description and Business Overview

6.3.3 Abnova Corporation Pertuzumab Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Abnova Corporation Pertuzumab Product Portfolio

6.3.5 Abnova Corporation Recent Developments/Updates

6.4 InvivoGen

6.4.1 InvivoGen Company Information

6.4.2 InvivoGen Description and Business Overview

6.4.3 InvivoGen Pertuzumab Sales, Revenue and Gross Margin (2020-2025)

6.4.4 InvivoGen Pertuzumab Product Portfolio

6.4.5 InvivoGen Recent Developments/Updates

6.5 Celltrion

6.5.1 Celltrion Company Information

6.5.2 Celltrion Description and Business Overview

6.5.3 Celltrion Pertuzumab Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Celltrion Pertuzumab Product Portfolio

6.5.5 Celltrion Recent Developments/Updates

6.6 Biocon Limited

6.6.1 Biocon Limited Company Information

6.6.2 Biocon Limited Description and Business Overview

6.6.3 Biocon Limited Pertuzumab Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Biocon Limited Pertuzumab Product Portfolio

6.6.5 Biocon Limited Recent Developments/Updates

6.7 Bio-Techne

6.7.1 Bio-Techne Company Information

6.7.2 Bio-Techne Description and Business Overview

6.7.3 Bio-Techne Pertuzumab Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Bio-Techne Pertuzumab Product Portfolio

6.7.5 Bio-Techne Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Pertuzumab Industry Chain Analysis

7.2 Pertuzumab Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Pertuzumab Production Mode & Process Analysis

7.4 Pertuzumab Sales and Marketing

7.4.1 Pertuzumab Sales Channels

7.4.2 Pertuzumab Distributors

7.5 Pertuzumab Customer Analysis

8 Pertuzumab Market Dynamics

8.1 Pertuzumab Industry Trends

8.2 Pertuzumab Market Drivers

8.3 Pertuzumab Market Challenges

8.4 Pertuzumab Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Novartis

Pfizer Inc

Abnova Corporation

InvivoGen

Celltrion

Biocon Ltd.

Bio-Techne

List of Tables

Table 1. Global Pertuzumab Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Pertuzumab Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Pertuzumab Market Competitive Situation by Manufacturers in 2024

Table 4. Global Pertuzumab Sales (MT) of Key Manufacturers (2020-2025)

Table 5. Global Pertuzumab Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Pertuzumab Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Pertuzumab Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Pertuzumab Average Price (USD/MT) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Pertuzumab, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Pertuzumab, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Pertuzumab, Product Type & Application

Table 12. Global Key Manufacturers of Pertuzumab, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Pertuzumab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pertuzumab as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Pertuzumab Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Pertuzumab Sales by Region (2020-2025) & (MT)

Table 18. Global Pertuzumab Sales Market Share by Region (2020-2025)

Table 19. Global Pertuzumab Sales by Region (2026-2031) & (MT)

Table 20. Global Pertuzumab Sales Market Share by Region (2026-2031)

Table 21. Global Pertuzumab Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Pertuzumab Revenue Market Share by Region (2020-2025)

Table 23. Global Pertuzumab Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Pertuzumab Revenue Market Share by Region (2026-2031)

Table 25. North America Pertuzumab Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Pertuzumab Sales by Country (2020-2025) & (MT)

Table 27. North America Pertuzumab Sales by Country (2026-2031) & (MT)

Table 28. North America Pertuzumab Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Pertuzumab Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Pertuzumab Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Pertuzumab Sales by Country (2020-2025) & (MT)

Table 32. Europe Pertuzumab Sales by Country (2026-2031) & (MT)

Table 33. Europe Pertuzumab Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Pertuzumab Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Pertuzumab Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Pertuzumab Sales by Region (2020-2025) & (MT)

Table 37. Asia Pacific Pertuzumab Sales by Region (2026-2031) & (MT)

Table 38. Asia Pacific Pertuzumab Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Pertuzumab Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Pertuzumab Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Pertuzumab Sales by Country (2020-2025) & (MT)

Table 42. Latin America Pertuzumab Sales by Country (2026-2031) & (MT)

Table 43. Latin America Pertuzumab Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Pertuzumab Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Pertuzumab Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Pertuzumab Sales by Country (2020-2025) & (MT)

Table 47. Middle East and Africa Pertuzumab Sales by Country (2026-2031) & (MT)

Table 48. Middle East and Africa Pertuzumab Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Pertuzumab Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Pertuzumab Sales (MT) by Type (2020-2025)

Table 51. Global Pertuzumab Sales (MT) by Type (2026-2031)

Table 52. Global Pertuzumab Sales Market Share by Type (2020-2025)

Table 53. Global Pertuzumab Sales Market Share by Type (2026-2031)

Table 54. Global Pertuzumab Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Pertuzumab Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Pertuzumab Revenue Market Share by Type (2020-2025)

Table 57. Global Pertuzumab Revenue Market Share by Type (2026-2031)

Table 58. Global Pertuzumab Price (USD/MT) by Type (2020-2025)

Table 59. Global Pertuzumab Price (USD/MT) by Type (2026-2031)

Table 60. Global Pertuzumab Sales (MT) by Application (2020-2025)

Table 61. Global Pertuzumab Sales (MT) by Application (2026-2031)

Table 62. Global Pertuzumab Sales Market Share by Application (2020-2025)

Table 63. Global Pertuzumab Sales Market Share by Application (2026-2031)

Table 64. Global Pertuzumab Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Pertuzumab Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Pertuzumab Revenue Market Share by Application (2020-2025)

Table 67. Global Pertuzumab Revenue Market Share by Application (2026-2031)

Table 68. Global Pertuzumab Price (USD/MT) by Application (2020-2025)

Table 69. Global Pertuzumab Price (USD/MT) by Application (2026-2031)

Table 70. Novartis AG Company Information

Table 71. Novartis AG Description and Business Overview

Table 72. Novartis AG Pertuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 73. Novartis AG Pertuzumab Product

Table 74. Novartis AG Recent Developments/Updates

Table 75. Pfizer Company Information

Table 76. Pfizer Description and Business Overview

Table 77. Pfizer Pertuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 78. Pfizer Pertuzumab Product

Table 79. Pfizer Recent Developments/Updates

Table 80. Abnova Corporation Company Information

Table 81. Abnova Corporation Description and Business Overview

Table 82. Abnova Corporation Pertuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 83. Abnova Corporation Pertuzumab Product

Table 84. Abnova Corporation Recent Developments/Updates

Table 85. InvivoGen Company Information

Table 86. InvivoGen Description and Business Overview

Table 87. InvivoGen Pertuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 88. InvivoGen Pertuzumab Product

Table 89. InvivoGen Recent Developments/Updates

Table 90. Celltrion Company Information

Table 91. Celltrion Description and Business Overview

Table 92. Celltrion Pertuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 93. Celltrion Pertuzumab Product

Table 94. Celltrion Recent Developments/Updates

Table 95. Biocon Limited Company Information

Table 96. Biocon Limited Description and Business Overview

Table 97. Biocon Limited Pertuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 98. Biocon Limited Pertuzumab Product

Table 99. Biocon Limited Recent Developments/Updates

Table 100. Bio-Techne Company Information

Table 101. Bio-Techne Description and Business Overview

Table 102. Bio-Techne Pertuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 103. Bio-Techne Pertuzumab Product

Table 104. Bio-Techne Recent Developments/Updates

Table 105. Key Raw Materials Lists

Table 106. Raw Materials Key Suppliers Lists

Table 107. Pertuzumab Distributors List

Table 108. Pertuzumab Customers List

Table 109. Pertuzumab Market Trends

Table 110. Pertuzumab Market Drivers

Table 111. Pertuzumab Market Challenges

Table 112. Pertuzumab Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Product Picture of Pertuzumab

Figure 2. Global Pertuzumab Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Pertuzumab Market Share by Type: 2024 & 2031

Figure 4. Human Source Product Picture

Figure 5. Animal Source Product Picture

Figure 6. Global Pertuzumab Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Pertuzumab Market Share by Application: 2024 & 2031

Figure 8. Hospital

Figure 9. Medical Center

Figure 10. Global Pertuzumab Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Pertuzumab Market Size (2020-2031) & (US$ Million)

Figure 12. Global Pertuzumab Sales (2020-2031) & (MT)

Figure 13. Global Pertuzumab Average Price (USD/MT) & (2020-2031)

Figure 14. Pertuzumab Report Years Considered

Figure 15. Pertuzumab Sales Share by Manufacturers in 2024

Figure 16. Global Pertuzumab Revenue Share by Manufacturers in 2024

Figure 17. Global 5 and 10 Largest Pertuzumab Players: Market Share by Revenue in Pertuzumab in 2024

Figure 18. Pertuzumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. Global Pertuzumab Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 20. North America Pertuzumab Sales Market Share by Country (2020-2031)

Figure 21. North America Pertuzumab Revenue Market Share by Country (2020-2031)

Figure 22. U.S. Pertuzumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 23. Canada Pertuzumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Europe Pertuzumab Sales Market Share by Country (2020-2031)

Figure 25. Europe Pertuzumab Revenue Market Share by Country (2020-2031)

Figure 26. Germany Pertuzumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. France Pertuzumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. U.K. Pertuzumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Italy Pertuzumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Russia Pertuzumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Pertuzumab Sales Market Share by Region (2020-2031)

Figure 32. Asia Pacific Pertuzumab Revenue Market Share by Region (2020-2031)

Figure 33. China Pertuzumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Japan Pertuzumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. South Korea Pertuzumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. India Pertuzumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Australia Pertuzumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Taiwan Pertuzumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Indonesia Pertuzumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Thailand Pertuzumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Malaysia Pertuzumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Philippines Pertuzumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America Pertuzumab Sales Market Share by Country (2020-2031)

Figure 44. Latin America Pertuzumab Revenue Market Share by Country (2020-2031)

Figure 45. Mexico Pertuzumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil Pertuzumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina Pertuzumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Pertuzumab Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Pertuzumab Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Pertuzumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Pertuzumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. U.A.E Pertuzumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Pertuzumab by Type (2020-2031)

Figure 54. Global Revenue Market Share of Pertuzumab by Type (2020-2031)

Figure 55. Global Pertuzumab Price (USD/MT) by Type (2020-2031)

Figure 56. Global Sales Market Share of Pertuzumab by Application (2020-2031)

Figure 57. Global Revenue Market Share of Pertuzumab by Application (2020-2031)

Figure 58. Global Pertuzumab Price (USD/MT) by Application (2020-2031)

Figure 59. Pertuzumab Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global HER2 Antibody Market Research Report 2025

Trastuzumab Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Trastuzumab Monoclonal Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Matuzumab Market Research Report 2024

Global Monoclonal Antibody Drugs for Cancer Market Research Report 2024

Global Therapeutic Monoclonal Antibodies Drug Market Research Report 2024

Global Therapeutic Monoclonal Antibodies Market Research Report 2024

Global Monoclonal Antibody VEGF Inhibitors Market Research Report 2024

Global HER2 Human Epidermal Growth Factor Receptor 2 Antibody Market Research Report 2024

Global Cancer Monoclonal Antibody Partnering Terms and Agreements Market Insights Forecast to 2030

Global Panitumumab Market Insights Forecast to 2030

Global Eculizumab Market Research Report 2024

Global Ofatumumab Market Research Report 2024

Global Dupilumab Injection Market Research Report 2024

Global Tocilizumab Drugs Market Research Report 2024

Global Mono Antibody mAb for HER2 Positive Advanced Breast Cancer Market Research Report 2024

Global Anti CD20 Monoclonal Antibodies Market Research Report 2024

Herceptin Trastuzumab and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ipilimumab Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions